A randomized placebo-controlled phase I clinical trial to evaluate the immunomodulatory activities of Atractylodes lancea (Thunb) DC. in healthy Thai subjects

BACKGROUND: Atractylodes lancea (Thunb) DC. (AL) and bioactive compounds β-eudesmol and atractylodin have been demonstrated in the in vitro and in vivo studies for their potential clinical use in cholangiocarcinoma. The study was a randomized, double-blinded, placebo-controlled phase I clinical tria...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Complement Med Ther
Hlavní autoři: Kulma, Inthuon, Panrit, Luxsana, Plengsuriyakarn, Tullayakorn, Chaijaroenkul, Wanna, Warathumpitak, Siriprapa, Na-Bangchang, Kesara
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879636/
https://ncbi.nlm.nih.gov/pubmed/33579265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-020-03199-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky